• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析患者双能光子吸收法测定的全身及局部骨矿物质密度

Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis.

作者信息

Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, Seto H, Sasayama S

机构信息

Second Department of Internal Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan.

出版信息

Clin Nephrol. 1992 Sep;38(3):149-53.

PMID:1395168
Abstract

To evaluate bone loss in renal osteodystrophy, we measured total and regional (head, trunk, pelvis, leg and arm) bone mineral density (BMD) by dual photon absorptiometry in 72 patients on maintenance hemodialysis (HD). We also examined the validity of serum carboxy-terminal parathyroid hormone (C-PTH) and intact-PTH as an indicator of secondary hyperparathyroidism. Total BMD correlated inversely with age in female patients (r = -0.57, p less than 0.01), but not in male patients. Female patients older than 50 years were omitted from analysis to exclude the effect of menopause on bone. Among clinical and biochemical parameters, only trunk BMD correlated inversely with the duration of HD (r = -0.26, p less than 0.05). Head, trunk and total BMD correlated inversely with serum alkaline phosphatase, C-PTH and intact-PTH, while pelvis BMD did not. Leg and arm BMD also correlated inversely with serum intact-PTH, but not with serum C-PTH. The serum level of C-PTH correlated positively with the duration of HD (r = 0.40, p less than 0.005), while intact-PTH did not. As compared with 18 control male volunteers aged 25-42 years, trunk, pelvis, leg, arm and total BMD were significantly lower in male patients on HD aged 22-49 years, whereas head BMD did not differ significantly between the two groups. The percent decrease of BMD was most prominent in the trunk (-19.6%, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为评估肾性骨营养不良中的骨质流失情况,我们采用双能光子吸收法测量了72例维持性血液透析(HD)患者的全身及局部(头部、躯干、骨盆、腿部和手臂)骨矿物质密度(BMD)。我们还检验了血清羧基末端甲状旁腺激素(C-PTH)和完整甲状旁腺激素(intact-PTH)作为继发性甲状旁腺功能亢进指标的有效性。女性患者的全身BMD与年龄呈负相关(r = -0.57,p < 0.01),而男性患者则不然。为排除绝经对骨骼的影响,分析时排除了年龄超过50岁的女性患者。在临床和生化参数中,只有躯干BMD与HD持续时间呈负相关(r = -0.26,p < 0.05)。头部、躯干和全身BMD与血清碱性磷酸酶、C-PTH和完整PTH呈负相关,而骨盆BMD则不然。腿部和手臂BMD也与血清完整PTH呈负相关,但与血清C-PTH无关。血清C-PTH水平与HD持续时间呈正相关(r = 0.40,p < 0.005),而完整PTH则不然。与18名年龄在25 - 42岁的男性对照志愿者相比,22 - 49岁的HD男性患者的躯干、骨盆、腿部、手臂和全身BMD显著降低,而两组之间的头部BMD无显著差异。BMD下降百分比在躯干最为显著(-19.6%,p < 0.001)。(摘要截选至250字)

相似文献

1
Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis.维持性血液透析患者双能光子吸收法测定的全身及局部骨矿物质密度
Clin Nephrol. 1992 Sep;38(3):149-53.
2
Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.甲状旁腺切除术对继发性甲状旁腺功能亢进血液透析患者骨密度的影响:术前测定甲状旁腺激素水平对预测骨恢复的可能作用。
Horm Metab Res. 2003 Apr;35(4):259-64. doi: 10.1055/s-2003-39483.
3
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.血清骨碱性磷酸酶作为预测低甲状旁腺激素的糖尿病血液透析患者骨密度降低的临床有用标志物。
Life Sci. 2005 Jul 22;77(10):1130-9. doi: 10.1016/j.lfs.2005.02.007.
4
Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.生物完整甲状旁腺激素(1-84)检测在血液透析患者中的意义
Osteoporos Int. 2005 May;16(5):517-25. doi: 10.1007/s00198-004-1715-1. Epub 2004 Aug 20.
5
Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism.西那卡塞对血液透析继发性甲状旁腺功能亢进症患者骨密度和骨标志物的影响。
Clin Exp Nephrol. 2013 Feb;17(1):120-6. doi: 10.1007/s10157-012-0665-8. Epub 2012 Jul 26.
6
[The relationship between bone mineral density and secondary hyperparathyroidism bone disease].骨密度与继发性甲状旁腺功能亢进性骨病之间的关系
Hunan Yi Ke Da Xue Xue Bao. 2000 Feb 28;25(1):77-9.
7
Studies on bone markers and bone mineral density in patients with chronic renal failure.慢性肾衰竭患者骨标志物及骨密度的研究
Yonsei Med J. 1996 Oct;37(5):350-6. doi: 10.3349/ymj.1996.37.5.350.
8
Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.采用双能X线吸收法评估持续性非卧床腹膜透析患者的骨矿物质密度。
Adv Perit Dial. 1996;12:245-9.
9
[Bioenergetic radiographic absorptiometry in hemodialysis].[血液透析中的生物能量射线吸收测定法]
An Med Interna. 1994 May;11(5):224-6.
10
Mineral bone disorder and osteoporosis in hemodialysis patients.血液透析患者的矿物质骨代谢紊乱与骨质疏松症
Adv Rheumatol. 2020 Feb 26;60(1):15. doi: 10.1186/s42358-020-0118-0.

引用本文的文献

1
Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance dialysis patients.单中心横断面研究:促红细胞生成素累积剂量对维持性透析患者骨密度的影响。
BMJ Open. 2022 Apr 12;12(4):e056390. doi: 10.1136/bmjopen-2021-056390.
2
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.血液透析患者中骨保护素与股骨颈骨密度的关联。
J Bone Miner Metab. 2008;26(1):66-72. doi: 10.1007/s00774-007-0785-5. Epub 2008 Jan 10.
3
Osteoporosis in the elderly with chronic kidney disease.
老年慢性肾脏病患者的骨质疏松症
Int Urol Nephrol. 2007;39(1):321-31. doi: 10.1007/s11255-006-9109-2. Epub 2006 Nov 11.
4
Changes in bone mineral density during the first year of dialysis treatment.透析治疗第一年期间骨矿物质密度的变化。
Int Urol Nephrol. 2004;36(2):285-6. doi: 10.1023/b:urol.0000034763.31477.89.
5
Bone density measurements in pediatric patients with renal osteodystrophy.患有肾性骨营养不良的儿科患者的骨密度测量
Pediatr Nephrol. 2003 Jun;18(6):554-9. doi: 10.1007/s00467-002-1041-9. Epub 2003 Apr 24.